Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Biomarker returned 64 record(s)
|
|
Sunday, 07/30/2017
|
Key Issues in Analyzing Big Data for Mental Health Studies: An Illustration Using Functional Data Analysis Methods for EEG
Catherine Ann Sugar, University of California, Los Angeles
2:30 PM
|
Statistical Methods for Developing Cost-Effective Biomarker Combinations for Disease Diagnosis and Prognosis
Aasthaa Bansal, University of Washington; Patrick Heagerty, University of Washington; Lotte Steuten, Fred Hutchinson Cancer Research Center
2:55 PM
|
Using Longitudinal Biomarker Data to Dynamically Predict Time to Disease Progression
Xuelin Huang, M D Anderson Cancer Center; Fangrong Yan, China Pharmaceutical Univeristy; Ruosha Li, University of Texas Health Science Center at Houston; Jing Ning, University of Texas MD Anderson Cancer Center; Xiao Lin, China Pharmaceutical University/MD Anderson Cancer Center
4:30 PM
|
|
Monday, 07/31/2017
|
Joint Modeling of Longitudinal Trajectories and Censoring Mechanism Using Shared Latent Random Variables
Miran Jaffa, American University of Beirut; Ayad A Jaffa, American University of Beirut
|
A Parametric Test for Comparing ROC Curves from Biomarkers with a Limit of Detection
Maria Pardo, Complutense University of Madrid; Alba María Franco Pereira, Complutense University of Madrid; Christos T. Nakas, University of Thessaly
|
Dynamic Prediction of Acute Graft-Versus-Host Disease (AGVHD) Using Longitudinal Biomarkers
Yumeng Li
|
An Algorithm for Detecting Melanoma Based on Imaging Biomarkers
Joel Correa da Rosa, Rockefeller University; Amanda Zong, The Rockefeller University; Daniel Gareau, The Rockefeller University
|
Biomarker Detection and Categorization in RNA-Seq Meta-Analysis Using Bayesian Hierarchical Model
Tianzhou Ma, Department of Biostatistics, University of Pittsburgh; Faming Liang, University of Florida; George Tseng, University of Pittsburgh
|
Combining Biomarkers for Risk Prediction Using Approximated Rank Correlation Statistic with Censored Survival Data
Eisuke Inoue, Medical Informatics, St. Marianna University School of Medicine
|
Biomarker-Based Cross-Sectional Incidence Estimation with Incomplete Data
Douglas Ezra Morrison, UCLA; Ron Brookmeyer, UCLA; Oliver Laeyendecker, Johns Hopkins University; Jacob Konikoff
|
Response Biomarker Versus Surrogate Endpoints Validation: Evolution of Statistical Approaches
Sue-Jane Wang, FDA
8:35 AM
|
Longitudinally Measured Predictors: Approaches for Sufficient Dimension Reduction
Efstathia Bura, TU Wien; Liliana Forzani, Universidad Nacional del Litoral; Ruth Pfeiffer , National Cancer Institute, NIH, HHS
8:35 AM
|
Biomarker Detection and Categorization in RNA-Seq Meta-Analysis Using Bayesian Hierarchical Model
Tianzhou Ma, Department of Biostatistics, University of Pittsburgh; Faming Liang, University of Florida; George Tseng, University of Pittsburgh
8:40 AM
|
Combining Biomarkers by Maximizing the True Positive Rate for a Fixed False Positive Rate
Allison Meisner, University of Washington; Marco Carone, University of Washington Department of Biostatistics; Margaret Pepe, Fred Hutchinson Cancer Research Center; Katie Kerr, University of Washington Department of Biostatistics
9:05 AM
|
Evaluating Classification Performance of Biomarkers in Two-Phase Case-Control Studies
Lu Wang, Fred Hutchinson Cancer Research Center; Ying Huang, Fred Hutchinson Cancer Research Center
10:05 AM
|
Risk Prediction from the Combination of Longitudinal Biomarkers Subject to Informative Missingness
Jiwei Zhao, State University of New York at Buffalo
10:55 AM
|
Discovery of Structural Brain Imaging Markers of HIV-Associated Outcomes Using Connectivity-Informed Regularization Approach
Jaroslaw Harezlak, Indiana University School of Public Health; Damian Brzyski, Indiana University; Marta Karas, Indiana University; Joaquin Goni, Purdue University; Beau Ances, Washington University School of Medicine; Timothy Randolph, Fred Hutchinson Cancer Research Center
10:55 AM
|
Combining Biomarkers for Risk Prediction Using Approximated Rank Correlation Statistic with Censored Survival Data
Eisuke Inoue, Medical Informatics, St. Marianna University School of Medicine
11:00 AM
|
An Adaptive Subgroup-Identification Enrichment Design
Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Florica Constantine, Johns Hopkins University
11:15 AM
|
Biomarker-Based Cross-Sectional Incidence Estimation with Incomplete Data
Douglas Ezra Morrison, UCLA; Ron Brookmeyer, UCLA; Oliver Laeyendecker, Johns Hopkins University; Jacob Konikoff
11:45 AM
|
Metabolite Prediction in the Human Microbiome
Himel Mallick, Harvard University; Eric A. Franzosa, Harvard University; Lauren J. Mclver, Harvard University; Soumya Banerjee, University of Oxford; Alexandra Sirota-Madi, Evelo Biosciences; Aleksandar D. Kostic, Harvard University; Clary B. Clish, Broad Institute; Hera Vlamakis, Broad Institute; Ramnik Xavier, Massachusetts General Hospital; Curtis Huttenhower, Harvard T.H. Chan School of Public Health
2:05 PM
|
Methods of Biomarker and Subgroup Identification for Personalized Medicine
Ilya Lipkovich, QuintilesIMS; Bohdana Ratitch , QuintilesIMS; Alex Dmitrienko, Mediana Inc
2:05 PM
|
Measuring Differential Treatment Benefit Across Marker Specific Subgroups: The Choice of Outcome Scale
Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center; Jaya Satagopan, Memorial Sloan Kettering Cancer Center
2:25 PM
|
Personalizing Early Detection for Ovarian Cancer with Hierarchical Longitudinal Models of a Blood Biomarker: Experience in Multiple Prospective Screening Trials
Steven Skates, MGH/Biostatistics Center
2:25 PM
|
Dynamic Prediction of End-Stage Renal Disease Using Longitudinal Biomarkers in a Cohort Study of Chronic Kidney Disease
Liang Li, University of Texas MD Anderson Cancer Center
2:25 PM
|
Joint Analysis of Left-Censored Longitudinal Biomarker and Binary Outcome via Latent Class Modeling
Menghan Li, Pennsylvania State University ; Lan Kong, Pennsylvania State University
2:35 PM
|
Personalizing Early Detection for Alzheimer's Disease: Biomarker Assessment in the Absence of a Gold Standard
Zheyu Wang, Johns Hopkins University; Yanxun Xu, Johns Hopkins University; Marilyn Albert, Johns Hopkins University
2:45 PM
|
ASID: A Bayesian Adaptive Subgroup-Identification Enrichment Design
Florica Constantine, Johns Hopkins University; Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Zhilin Jin, Johns Hopkins University
2:50 PM
|
Evaluating Risk Prediction Tests to Guide Decisions on Prophylactic Treatment
Gene Pennello, Food and Drug Administration; Robert L Becker, Food and Drug Administration
3:25 PM
|
A Flexible Joint Longitudinal-Survival Model for a Simultaneous Modeling of Multiple Longitudinal Biomarkers
Sepehr Akhavan Masouleh, UC Irvine; Babak Shahbaba, University of California, Irvine; Alexander Vandenberg-Rodes, UC Irvine; Daniel L. Gillen, University of California, Irvine
3:25 PM
|
|
Tuesday, 08/01/2017
|
Evidence Collection and Evaluation on Acrolein Biomarkers in Urine Resulting from Exposure to Tobacco and Non-Tobacco Products
Juan Vivar, Food and Drug Administration, Center for Tobacco Products; Qian Li, Food and Drug Administration; Eric Backlund, Food and Drug Administration, Center for Tobacco Products; Derick Rivers, Food and Drug Administration, Center for Tobacco Products
|
A Bayesian Approach to Analyzing Gene Expression in Heterogeneous Tissue Samples
Megan Stefanski, University of Missouri - Kansas City; David Spade, University of Missouri - Kansas City
|
Comparing Biomarker-Guided Treatment Strategies Using Local Posterior Predictive Benefit
Meilin Huang, The University of Texas MD Anderson Cancer Center; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
|
On Measure of Surrogacy for Biomarkers in Medical Research.
Rui Zhuang, University of Washington; Ying Qing Chen, Fred Hutchinson Cancer Research Center
|
Combining Different Data Sources in Accelerometry Study
Jiawei Bai, Johns Hopkins University; Chongzhi Di, Fred Hutchinson Cancer Research Center; Ciprian M Crainiceanu, Johns Hopkins University
|
Tests and Classifications in Adaptive Designs with Applications
Qiusheng Chen, Florida State University; Xufeng Niu, Florida State University
8:35 AM
|
A Two-Stage Design for Phase III Trials with Population Selection
Wen Li, Merck & Co. Inc.
8:50 AM
|
Comparing Biomarker-Guided Treatment Strategies Using Local Posterior Predictive Benefit
Meilin Huang, The University of Texas MD Anderson Cancer Center; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
8:55 AM
|
On Measure of Surrogacy for Biomarkers in Medical Research.
Rui Zhuang, University of Washington; Ying Qing Chen, Fred Hutchinson Cancer Research Center
9:10 AM
|
Risk Screening for Alzheimer's Disease Progression with Volume Under the ROC Surface
Yu Cheng, University of Pittsburgh Department of Statistics
9:15 AM
|
Quantile Residual Life Regression with Longitudinal Biomarker Measurements for Dynamic Prediction
Ruosha Li, University of Texas Health Science Center at Houston; Xuelin Huang, M D Anderson Cancer Center
9:35 AM
|
New Adaptive Designs of Clinical Trial for Precision Medicine
Feifang Hu, George Washington University
10:35 AM
|
Flexible Bayesian Additive Joint Models
Meike Köhler, Helmholtz Zentrum München; Nikolaus Umlauf, Universität Innsbruck; Sonja Greven, Ludwig-Maximilians-Universität München
11:00 AM
|
Combining Different Data Sources in Accelerometry Study
Jiawei Bai, Johns Hopkins University; Chongzhi Di, Fred Hutchinson Cancer Research Center; Ciprian M Crainiceanu, Johns Hopkins University
11:25 AM
|
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Genetic Association Landscape by Functional Linear Models.
Olga Vsevolozhskaya; Ilai Keren, Washington Department of Fish and Wildlife; David Fardo, University of Kentucky; Dmitri Zaykin, NIH/NIEHS
11:35 AM
|
|
Wednesday, 08/02/2017
|
Statistical Inference in the Era of Precision Medicine- the Essential Role of Statistics for Unmet Needs in Algorithm Refinement, Diagnostics Application and Drug Development
Ruixiao Lu, Genomic Health
|
Statistical Challenges and Possible Career Path in Aging and Dementia Research
Chengjie Xiong, Washington University School of Medicine
|
Functional Cox Model for Longitudinal Biomarkers
Jiehuan Sun, Department of Biostatistics, Yale Univeristy; Jose D. Herazo-Maya, Yale School of Medicine; Naftali Kaminski, Yale School of Medicine; Hongyu Zhao, Yale University
|
Effect Modifications of Blood Lead-Cardiovascular Disease Mortality Association by Time-Related Factors Studied Using NHANES Linked Mortality Files
Yutaka Aoki, National Center for Health Statistics; Jennifer Parker, National Center for Health Statistics
|
Improving Subgroup Identification: Type I Error Control, Power, and the Quality of Subgroups
Lei Shen, Eli Lilly and Company
8:55 AM
|
Test for a Change Point in the Linear Combination of Risk Predictors
Ju Hee Cho, Fred Hutchinson Cancer Research Center; Ying Huang, Fred Hutchinson Cancer Research Center
9:20 AM
|
Functional Cox Model for Longitudinal Biomarkers
Jiehuan Sun, Department of Biostatistics, Yale Univeristy; Jose D. Herazo-Maya, Yale School of Medicine; Naftali Kaminski, Yale School of Medicine; Hongyu Zhao, Yale University
9:40 AM
|
Accounting for Genetics in Biomarker-Disease Association Studies: Lessons Learned from Lung Disease
Katerina Kechris, University of Colorado Anschutz Medical Campus; Wei Sun, Fred Hutchinson Cancer Research Center; Sean Jacobson, National Jewish Health; Wanda O'Neal, University of North Carolina at Chapel Hill; Russell Bowler, National Jewish Health
9:50 AM
|
Estimand in Evaluating Predictive or Selection Markers Using Enrichment Design in Clinical Trials
Jingjing Ye, FDA
9:55 AM
|
Effect Modifications of Blood Lead-Cardiovascular Disease Mortality Association by Time-Related Factors Studied Using NHANES Linked Mortality Files
Yutaka Aoki, National Center for Health Statistics; Jennifer Parker, National Center for Health Statistics
10:05 AM
|
New Machine Learning Tools for Discovering and Utilizing Biomarkers in Precision Medicine
Daniel Luckett, University of North Carolina at Chapel Hill; Eric Laber, North Carolina State University; Michael R Kosorok, University of North Carolina at Chapel Hill
10:55 AM
|
Biomarker Based Study Design with Multiple Single Arms
Shiling Ruan, Novartis
11:35 AM
|
Evaluation of Subgroup-Specific Incremental Value of New Markers for Treatment Selection
Ying Huang, Fred Hutchinson Cancer Research Center
11:55 AM
|
Statistical Methods to Asses Cancer Immune Microenvironment to Identify Biomarkers for Cancer Immunotherapy
Wei Sun, Fred Hutchinson Cancer Research Center
2:05 PM
|
High-Dimensional Precision Medicine from Patient Derived Xenograft Data
Naim Rashid, University of North Carolina at Chapel Hill; Jingxiang Chen, University of North Carolina at Chapel Hill; Michael Lawson, University of North Carolina at Chapel Hill; Daniel Luckett, University of North Carolina at Chapel Hill; Longshaokan Wang, North Carolina State University; Eric Laber, North Carolina State University; Yufeng Liu, University of North Carolina; Jen Jen Yeh, University of North Carolina at Chapel Hill; Donglin Zeng, University of North Carolina; Michael R Kosorok, University of North Carolina at Chapel Hill
2:35 PM
|
|
Thursday, 08/03/2017
|
Calibration and Seasonal Adjustment for Matched Case-Control Studies of Vitamin D and Cancer
Mitchell Gail , National Cancer Institute, NIH, HHS; Jincao Wu, Food and Drug Administration; Molin Wang, Harvard T. H. Chan School of Public Health and Channing Division of Network Medicine; Shiaw-Shyuan Yaun, Harvard T. H. Chan School of Public Health; Nancy R. Cook, Harvard T. H. Chan School of Public Health; A. Heather Eliassen, Harvard T. H. Chan School of Public Health; Marjorie L McCullough, American Cancer Society; Kai Yu, National Cancer Institute; Anne Zeleniuch-Jacquotte, New York University School of Medicine; Stephanie A. Smith-Warner, Harvard T. H. Chan School of Public Health; Regina G. Ziegler, National Cancer Institute; Raymond Carroll, Texas A&M University
11:20 AM
|
Multi-Arm Bayesian Designs for Clinical Trials
Lorenzo Trippa, Dana-Farber Cancer Institute, Harvard
11:25 AM
|
Method Development for the Analysis of Pooled Biomarker Data
Abigail Sloan, Harvard T.H. Chan School of Public Health; Molin Wang, Harvard T. H. Chan School of Public Health and Channing Division of Network Medicine
11:35 AM
|
Optimizing Patient Selection for Chemoprevention Through Predictive Modeling
Xi Kathy K Zhou, Weill Cornell Medical College
11:50 AM
|
|
|
